Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9378(97)70294-1PMID 9369845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein

  2004cited by this paper
• Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.

  1994cited by this paper
• The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation.

  1994cited by this paper
• The immunobiology and obstetrical consequences of antiphospholipid antibodies.

  1994cited by this paper
• Annexin V-crystal structure and its implications on function.

  1992cited by this paper
• Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.

  1991cited by this paper
• Platelet adhesion to exposed endothelial cell extracellular matrixes is influenced by the method of preparation.

  1991cited by this paper
• [Distribution and motion of calphobindin in the human body].

  1991cited by this paper
• Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system.

  1990cited by this paper
• Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family.

  1988cited by this paper
• Human placental anticoagulant protein: isolation and characterization.

  1987cited by this paper
• Steroid metabolizing enzymes associated with the microvillar membrane of human placenta.

  1986cited by this paper
• Characterization of a microvillous membrane preparation from human placental syncytiotrophoblast: a morphologic, biochemical, and physiologic, study.

  1977cited by this paper

• Immune-mediated mechanisms and maternal-fetal interface dysfunction in obstetric antiphospholipid syndrome

  2025cites this paper
• Impact of Antiphospholipid Syndrome on Reproductive Outcomes: Current Insights and Management Approaches

  2024cites this paper
• The pathogenesis of obstetric APS: a 2023 update.

  2023cites this paper
• “In House” assays for the quantification of Annexin V and its autoantibodies in patients with recurrent pregnancy loss and in vitro fertilisation failures

  2023cites this paper
• HEREDITARY THROMBOPHILIA IN RECURRENT IVF FAILURE

  2021cites this paper
• Inherited thrombophilia and anticoagulant therapy for women with reproductive failure

  2020cites this paper
• A case report of a patient with a live born child from the 14th pregnancy after 13 spontaneous abortion, diagnosed with systemic lupus erythematosus and antiphospholipid syndrome

  2019influential citation
• Fetal Autopsy and Placental Examination as a Complimentary Tool

  2018cites this paper
• Recurrent Pregnancy Loss

  2018cites this paper
• Current insights in obstetric antiphospholipid syndrome

  2017cites this paper
• The role of anti-phospholipid antibodies in autoimmune reproductive failure.

  2016cites this paper
• Pregnancy and Antiphospholipid Syndrome

  2016cites this paper
• Hydroxychloroquine Prevents Antiphospholipid Antibody-Induced Inhibition Of Trophoblast Migration

  2015cites this paper
• Antiphospholipid Syndrome–Not a Noninflammatory Disease

  2015cites this paper
• Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature.

  2015cites this paper
• Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment.

  2015cites this paper
• Annexin V expression and anti-annexin V antibodies in type 1 diabetes.

  2014cites this paper
• Multicentre study of the clinical relevance of screening IVF patients for carrier status of the annexin A5 M2 haplotype.

  2014cites this paper
• The chequered history of the antiphospholipid syndrome

  2014cites this paper
• Recurrent IVF failure and hereditary thrombophilia

  2014cites this paper
• Serological Biomarkers in Systemic Lupus Erythematosus

  2013cites this paper
• Role of the complement in pregnancy with antiphospholipid syndrome: mechanisms of pathogenesis and clinical aspects

  2013cites this paper
• haystack Pathogenic antiphospholipid antibody: an antigen-selected needle in a

  2013cites this paper
• The haplotype M2 of the ANXA5 gene is not associated with antitrophoblast antibodies

  2013cites this paper
• Role of anti‐annexin A5 in pathogenesis of hypercoagulable state in patients with antiphospholipid syndrome

  2013cites this paper
• A5 2-glycoprotein I and a reduction in the anticoagulant activity of annexin β Correlation between antiphospholipid antibodies that recognize domain I of

  2013cites this paper
• Annexin A5 as independent predictive biomarker for subclinical atherosclerosis and endothelial dysfunction in systemic lupus erythematosus patients.

  2013cites this paper
• F2α-isoprostane, Na + -K + ATPase and membrane fluidity of placental syncytiotrophoblast cell in preeclamptic women with vitamin E supplementation

  2012cites this paper
• Intrauterine fetal death: classification and risk factors : A case-control study of sociodemographic, clinical and thrombophilic risk factors

  2012cites this paper
• Antiphospholipid Syndrome - An Evolving Story of a Multisystemic Disease

  2012cites this paper
• The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study.

  2012influential citation
• Pathogenesis of the Antiphospholipid Syndrome

  2012cites this paper
• Antiphospholipid Syndrome: Changing Knowledge During the Time – The ”Four P” Pattern

  2012cites this paper
• Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study.

  2012cites this paper
• Expresión de factor tisular, trombomodulina y PAI-1 en placentas de pacientes con restricción de crecimiento intrauterino o preeclampsia

  2011cites this paper
• Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis.

  2011cites this paper
• Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome.

  2011cites this paper
• Effects of anti‐β2‐glycoprotein I antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line

  2011cites this paper
• Pathophysiology of the antiphospholipid antibody syndrome

  2011cites this paper
• Fertility, Infertility and Thrombophilia

  2011cites this paper
• The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies.

  2011cites this paper
• Antiphospholipid Syndrome: Pathogenesis

  2011cites this paper
• Histopathologic exam of the placenta, membranes and umbilical cord: essential step in orienting the standard complex investigation of recurrent abortion

  2011cites this paper
• Histopathological Placental Screening as Valuable and Non-Invasive Method for Assessing Etiology of Second Trimester Recurrent Abortion

  2010cites this paper
• Anti-annexin V Antibodies in Women with Recurrent Miscarriage

  2010cites this paper
• Pleading for the Routine Introduction in the Investigation of the Late Spontaneous Abortion Etiology of the Exploration of Resistance to Activated C Protein Along With Histopathological Placentary Screening

  2010influential citation
• Therapeutic abortion in the second trimester of pregnancy

  2010cites this paper
• Circulating Lymphocyte Immunophenotypation by Flow Cytometry as Fast and Efficient Method for Immune Status Assessment in Second Trimester of Normal Pregnancy and Pregnancy Complicated by Miscarriage

  2010cites this paper
• Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.

  2010cites this paper
• Predictors of Pregnancy Outcome in Antiphospholipid Syndrome: A Review

  2010cites this paper
• Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction.

  2010cites this paper
• Immunological Characterization of Late Miscarriage

  2010cites this paper
• In vitro model of annexin A5 crystallization on natural phospholipid bilayers observed by atomic force microscopy

  2009cites this paper
• Management of the antiphospholipid syndrome: new approaches

  2009cites this paper
• The effect of severity of pre-eclampsia on the basal plate intervillous surface lining components : a confocal laser scanning microscopy study

  2009cites this paper
• OUTCOME OF IN-VITRO FERTILIZATION AND THE AUTO ANTIBODIES AGAINST ANNEXIN V AND CARDIOLIPIN

  2008cites this paper
• 61 – Antiphospholipid syndrome

  2008cites this paper
• [Pregnancy and antiphospholipid antibodies].

  2008cites this paper
• Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia.

  2007cites this paper
• Uterine Artery Velocity Waveforms as Predictors of Pregnancy Outcome in Patients with Antiphospholipid Syndrome

  2007cites this paper
• Investigating the molecular targets of antiphospholipid antibodies

  2007cites this paper
• Annexin A5 as a Novel Player in Prevention of Atherothrombosis in SLE and in the General Population

  2007cites this paper
• Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

  2007cites this paper
• Annexin A5 multitasking: a potentially novel antiatherothrombotic agent?

  2007cites this paper
• Regulation der Bindung von Annexin 6 an

  2006cites this paper
• Annexin V C/T-1 polymorphism and pregnancy complications.

  2006cites this paper
• Obstetric Antiphospholipid Syndrome

  2006cites this paper
• [Preeclampsia and antiphospholipid syndrome. Uterine artery Doppler evaluation].

  2006cites this paper
• Annexin A5 polymorphism (−1C→T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome

  2006cites this paper
• Prééclampsie et syndrome des antiphospholipides. Intérêt du Doppler utéroplacentaire

  2006cites this paper
• Analysis of circulating annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls.

  2006cites this paper
• Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses.

  2006cites this paper
• Annexins in Antiphospholipid Syndrome

  2006cites this paper
• Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction.

  2006cites this paper
• 17 Obstetric Antiphospholipid Syndrome

  2006cites this paper
• [Changes of complement in recurrent abortion and pregnancy loss with antiphospholipid antibody positive].

  2006cites this paper
• Placental Pathology in Antiphospholipid Syndrome

  2006cites this paper
• Obstetrical Antiphospholipid Syndrome

  2006cites this paper
• Defective annexin A5 crystallization: a mechanism for pregnancy losses in the antiphospholipid syndrome.

  2005cites this paper
• A Prospective Study of 1038 Pregnancies on the Predictive Value of Anti‐Annexin V Antibodies for Fetal Loss

  2005cites this paper
• Pathogenesis of antiphospholipid syndrome.

  2005cites this paper
• The impact of β-hCG on placental angiogenesis in pre-eclampsia

  2005cites this paper
• Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.

  2005cites this paper
• Anti-annexin V antibodies: are they prothrombotic?

  2005cites this paper
• Delayed cutaneous reactions to heparin in antiphospholipid syndrome during pregnancy

  2004cites this paper
• Antibody-mediated interference with annexins in the antiphospholipid syndrome.

  2004cites this paper
• IVIG in APS pregnancy

  2004cites this paper
• Antiphospholipid antibodies and fetal compromise.

  2004cites this paper
• 102 – Pregnancy—Success or Failure: The Influence of Autoimmune Diseases

  2004cites this paper
• Decreased Binding of Annexin V to Endothelial Cells: A Potential Mechanism in Atherothrombosis of Patients With Systemic Lupus Erythematosus

  2004cites this paper
• Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack.

  2004cites this paper
• Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.

  2003cites this paper
• Procoagulant and Anticoagulant Mechanisms in Human Placenta

  2003cites this paper
• Pregnancy outcome in women with antiphospholipid syndrome and alloimmunity: a case report

  2003cites this paper
• L'effet des statines sur l'activation des cellules endothéliales par les anticorps antiphospholipides

  2003cites this paper
• Thrombophilic disorders and fetal loss: a meta-analysis.

  2003cites this paper
• Haemostatic mechanisms in human placenta.

  2003cites this paper
• Annexinopathy in the Antiphospholipid Syndrome

  2003cites this paper
• Autoimmune factors and their influence on assisted reproduction

  2002cites this paper
• Tissue Factor, Protein C Pathway, and Other Hemostasis Abnormalities in the Pathogenesis of the Antiphospholipid Syndrome

  2002cites this paper